Medelpharm’s compaction simulators add capabilities for early-stage material characterization and scale-up to Korsch’s R&D product portfolio.
Tablet-press manufacturer Korsch AG (Berlin) has acquired Medelpharm, a supplier of compaction simulator technology. Medelpharm’s compaction simulators add capabilities for early-stage material characterization and scale-up to Korsch’s R&D product portfolio. The companies had already been working closely together for more than a year as partners prior to the acquisition.
Korsch’s R&D portfolio is designed to address and overcome challenges like early-stage powder characterization, formulation development, predictive scale-up, and production support. “Covering the full spectrum of tableting technology from single-layer to five-layer as well as core coating capabilities, the new R&D product equipment portfolio serves as a versatile complement to Korsch’s multilayer production machinery,” the company’s press release states.
The new, combined Korsch-Medelpharm R&D equipment line includes XP 1, a robust, single-punch tablet press with small-batch capabilities; Styl’One Nano, a benchtop compaction simulator with integrated analytical software for single-layer formulation development; Styl’One Evo, an advanced compaction simulator with integrated analytical software and multilayer capability, allowing R&D at production speed; and XL 100, a small-scale rotary press for product development and clinical batch production.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.